Atrion (NASDAQ:ATRI) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Atrion (NASDAQ:ATRI) in a report issued on Thursday. The brokerage issued a sell rating on the medical instruments supplier’s stock.

Atrion Stock Performance

Shares of Atrion stock opened at $459.92 on Thursday. The business has a fifty day simple moving average of $458.99 and a two-hundred day simple moving average of $445.50. The firm has a market capitalization of $809.46 million, a P/E ratio of 43.23 and a beta of 0.69. Atrion has a 12 month low of $274.98 and a 12 month high of $503.24.

Atrion (NASDAQ:ATRI) last issued its quarterly earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 earnings per share (EPS) for the quarter. The company had revenue of $48.77 million during the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ATRI. Penn Mutual Asset Management LLC purchased a new stake in shares of Atrion in the fourth quarter worth $1,949,000. Public Employees Retirement System of Ohio bought a new position in Atrion in the 1st quarter worth about $2,299,000. Jump Financial LLC purchased a new stake in Atrion during the 4th quarter valued at about $234,000. Sei Investments Co. increased its stake in Atrion by 59.7% during the 1st quarter. Sei Investments Co. now owns 1,774 shares of the medical instruments supplier’s stock valued at $822,000 after purchasing an additional 663 shares in the last quarter. Finally, Quadrant Capital Group LLC purchased a new position in Atrion in the fourth quarter worth about $36,000. Institutional investors own 66.19% of the company’s stock.

About Atrion

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.